Literature DB >> 20663349

MR Quantification of Flow in Children with Vascular Malformations.

K J Poskitt1, T Marotta, C Haw, D Cochrane, P Steinbok.   

Abstract

SUMMARY: The evaluation of treatments such as embolization, stereotactic radiation, and even surgery would be enhanced by an objective method of measuring flow in feeding arteries or draining veins. We developed a non-invasive method of measuring vascular flow using cardiac gated phase contrast MR angiography (MR Q flow). The purpose of this work was to employ the same technique in a series of patients with vascular malformations of the head and neck. We selected a series of vascular malformations with simple arterial and venous architecture and significantly smaller vessel diameters than that encountered with Vein of Calen Malformations. Our aim was to determine the reproducibility of the derived flow values by using multiple velocity encoded sequences (VENC) and compare the values derived from the arterial feeders to the venous outflow data. There are inherent technical difficulties with assessing flow through multiple arterial feeders or draining veins, so the technique is most easily applied to AVMs with simple, easily defined feeding arteries or draining veins. Nonetheless, this technique is relatively straightforward to learn, rapid, cost-effective and may provide an objective means to assess therapeutic maneuvers when applied to head and neck vascular malformations.

Entities:  

Year:  2001        PMID: 20663349      PMCID: PMC3621057          DOI: 10.1177/159101990100700304

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  12 in total

1.  Accuracy of segmented MR velocity mapping to measure small vessel pulsatile flow in a phantom simulating cardiac motion.

Authors:  H Arheden; M Saeed; E Törnqvist; G Lund; M F Wendland; C B Higgins; F Ståhlberg
Journal:  J Magn Reson Imaging       Date:  2001-05       Impact factor: 4.813

Review 2.  MR measurement of blood flow in the cardiovascular system.

Authors:  G H Mostbeck; G R Caputo; C B Higgins
Journal:  AJR Am J Roentgenol       Date:  1992-09       Impact factor: 3.959

3.  Factors influencing the accuracy and precision of velocity-encoded phase imaging.

Authors:  M H Buonocore; H Bogren
Journal:  Magn Reson Med       Date:  1992-07       Impact factor: 4.668

Review 4.  Phase contrast cine magnetic resonance imaging.

Authors:  N J Pelc; R J Herfkens; A Shimakawa; D R Enzmann
Journal:  Magn Reson Q       Date:  1991-10

5.  Verification and evaluation of internal flow and motion. True magnetic resonance imaging by the phase gradient modulation method.

Authors:  P R Moran; R A Moran; N Karstaedt
Journal:  Radiology       Date:  1985-02       Impact factor: 11.105

6.  The application of magnetization transfer to MR angiography with reduced total power.

Authors:  D L Parker; H R Buswell; K C Goodrich; A L Alexander; N Keck; J S Tsuruda
Journal:  Magn Reson Med       Date:  1995-08       Impact factor: 4.668

7.  Accuracy of phase-contrast flow measurements in the presence of partial-volume effects.

Authors:  C Tang; D D Blatter; D L Parker
Journal:  J Magn Reson Imaging       Date:  1993 Mar-Apr       Impact factor: 4.813

8.  Intracranial arteries: prospective blinded comparative study of MR angiography and DSA in 50 patients.

Authors:  K W Stock; E W Radue; A L Jacob; X S Bao; W Steinbrich
Journal:  Radiology       Date:  1995-05       Impact factor: 11.105

9.  Determination of cerebral blood flow with a phase-contrast cine MR imaging technique: evaluation of normal subjects and patients with arteriovenous malformations.

Authors:  M P Marks; N J Pelc; M R Ross; D R Enzmann
Journal:  Radiology       Date:  1992-02       Impact factor: 11.105

10.  Intracranial arteriovenous malformations: quantitative analysis of magnitude contrast MR angiography versus gradient-echo MR imaging versus conventional angiography.

Authors:  S K Mukherji; R G Quisling; P S Kubilis; J P Finn; W A Friedman
Journal:  Radiology       Date:  1995-07       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.